Abstract
A solution of bleomycin (BLM) and desferrioxamine B (DFOB) was resolved using two in-series columns containing BLM- or DFOB-tailored IMAC resin as a method with potential for accessing multiple clinical agents from fermentation.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
